G. Riethmüller

11.2k total citations
137 papers, 8.9k citations indexed

About

G. Riethmüller is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, G. Riethmüller has authored 137 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 49 papers in Radiology, Nuclear Medicine and Imaging and 43 papers in Oncology. Recurrent topics in G. Riethmüller's work include Monoclonal and Polyclonal Antibodies Research (45 papers), Immunotherapy and Immune Responses (23 papers) and Immune Cell Function and Interaction (21 papers). G. Riethmüller is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (45 papers), Immunotherapy and Immune Responses (23 papers) and Immune Cell Function and Interaction (21 papers). G. Riethmüller collaborates with scholars based in Germany, Croatia and United States. G. Riethmüller's co-authors include Günter Schlimok, Klaus Pantel, Jens Witte, I. Funke, Peter Kufer, Jennifer Johnson, J�rgen Lehmann, Fritz Lindemann, Matthias Mack and J. P. Johnson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

G. Riethmüller

132 papers receiving 8.5k citations

Peers

Countries citing papers authored by G. Riethmüller

Since Specialization

Citations

This map shows the geographic impact of G. Riethmüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Riethmüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Riethmüller more than expected).

Fields of papers citing papers by G. Riethmüller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Riethmüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Riethmüller. The network helps show where G. Riethmüller may publish in the future.

Co-authorship network of co-authors of G. Riethmüller

This figure shows the co-authorship network connecting the top 25 collaborators of G. Riethmüller. A scholar is included among the top collaborators of G. Riethmüller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Riethmüller. G. Riethmüller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. 2001 ·PubMed ·Sepp Braun, G. Schlimok, (unknown), G. Eric Schaller, Lutz Riethdorf, G. Riethmüller, Klaus Pantel	151
2	Monoklonale Antikörper: Entwicklung und klinische Perspektiven 2001 ·Der Internist ·Peter Borchmann, G. Riethmüller, Andreas Engert	0
3	Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells 2000 ·Cytotherapy ·(unknown), Peter E. Müller, Daniel Oruzio, (unknown), Carsten Brockmeyer, (unknown), (unknown), G. Riethmüller, Günter Schlimok	19
4	Disseminierte Tumorzellen: Diagnostik, prognostische Relevanz, Phänotypisierung und therapeutische Strategien 1997 ·Der Chirurg ·Klaus Pantel, (unknown), Jakob R. Izbicki, G. Riethmüller	27
5	Construction and biological activity of a recombinant bispecific single-chain antibody designed for therapy of minimal residual colorectal cancer 1997 ·Cancer Immunology Immunotherapy ·Peter Kufer, Matthias Mack, Rudolf Gruber, Ralf Lutterbüse, Florian Zettl, G. Riethmüller	37
6	Micrometastasis Detection and Treatment with Monoclonal Antibodies 1996 ·Current topics in microbiology and immunology ·Klaus Pantel, G. Riethmüller	30
7	Monoclonal Antibodies in the Therapy of Minimally Residual Solid Tumors 1995 ·Oncology Research and Treatment ·Günter Schlimok, G. Riethmüller	4
8	Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer 1995 ·European Journal of Cancer ·Klaus Pantel, (unknown), Jens Köllermann, (unknown), G. Riethmüller, M. W. Köllermann	34
9	Establishment of Micrometastatic Carcinoma Cell Lines: a Novel Source of Tumor Cell Vaccines 1995 ·JNCI Journal of the National Cancer Institute ·Klaus Pantel, Achim Dickmanns, Alfred Zippelius, Christian Klein, Jianwei Shi, (unknown), Günter Schlimok, Dorothea Weckermann, R. Oberneder, Ellen Fanning, G. Riethmüller	95
10	Characteristics of Carcinoembryonic Antigen (CEA) Expressed in Different Cell-Types: Evidence That CEA Can Function as an Adhesion Molecule and as a Repulsion Molecule 1994 ·Biochemical and Biophysical Research Communications ·Thomas W. Grimm, G. Riethmüller, J. P. Johnson	19
11	A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantation. 1992 ·PubMed ·(unknown), Christian Reiter, (unknown), P Überfuhr, K Wenke, Hermann Reichenspurner, E P Rieber, G. Riethmüller, Bruno Reichart	2
12	Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients 1992 ·The Lancet ·Fritz Lindemann, Jens Witte, Günter Schlimok, P. Dirschedl, G. Riethmüller	438
13	Anti-idiotypic Antibodies Against Anti-CD4 Antibodies MT151 and OKT4A 1991 ·Viral Immunology ·Shaohong Liang, P. Rieber, Marie Prewett, G. Riethmüller, Charles H. Pletcher, James A. Hoxie, Hilary Koprowski, Dorothee Herlyn	0
14	Expression of the CD6 T lymphocyte differentiation antigen in normal human brain 1990 ·Journal of Neuroimmunology ·Barbara Mayer, I. Funke, Brian Seed, G. Riethmüller, Elisabeth H. Weiss	28
15	Biosynthesis of Complement C4 Messenger RNA in Normal Human Kidney 1989 ·The Nephron journals/Nephron journals ·Helmut E. Feucht, Jörg Zwirner, Dorian Bevec, (unknown), E. Felber, G. Riethmüller, Elisabeth H. Weiss	37
16	Deposition of complement activation products on plastic-adsorbed immunoglobulins 1989 ·Journal of Immunological Methods ·Jörg Zwirner, E. Felber, Christian Reiter, G. Riethmüller, Helmut E. Feucht	20
17	Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen 1988 ·International Journal of Cancer ·Bernhard Holzmann, J�rgen Lehmann, H.W.L. Ziegler-Heitbrock, I. Funke, G. Riethmüller, J. P. Johnson	39
18	The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. 1987 ·The Journal of Experimental Medicine ·I. Funke, Amy B. Hahn, E. Peter Rieber, Elisabeth H. Weiss, G. Riethmüller	99
19	Monocyte Phenotype and Function in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and AIDS‐Related Disorders 1987 ·Scandinavian Journal of Immunology ·Judith Haas, G. Riethmüller, H.W.L. Ziegler-Heitbrock	36
20	The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen. 1984 ·PubMed Central ·H.W.L. Ziegler-Heitbrock, Agnes Fütterer, Helmut Rumpold, Dietrich Kraft, Reinhold Munker, G. Riethmüller	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact